Structure-based redesign of an edema toxin inhibitor.

Authors:
Address: Sealy Center for Structural Biology and Molecular Biophysics, Department of Biochemistry and Molecular Biology, UTMB, Galveston, TX 77555-0857, USA.
Journal:

Publication:

abstract

edema factor (EF) toxin of Bacillus anthracis (NIAID category A), and several other toxins from NIAID category B Biodefense target bacteria are adenylyl cyclases or adenylyl cyclase agonists that catalyze the conversion of ATP to 3',5'-cyclic adenosine monophosphate (cAMP). We previously identified compound 1 (3-[(9-oxo-9H-fluorene-1-carbonyl)-amino]-benzoic acid), that inhibits EF activity in cultured mammalian cells, and reduces diarrhea caused by enterotoxigenic Escherichia coli (ETEC) at an oral dosage of 15μg/mouse. Here, molecular docking was used to predict improvements in potency and solubility of new derivatives of compound 1 in inhibiting edema toxin (ET)-catalyzed stimulation of cyclic AMP production in murine monocyte-macrophage cells (RAW 264.7). Structure-activity relationship (SAR) analysis of the bioassay results for 22 compounds indicated positions important for activity. Several derivatives demonstrated superior pharmacological properties compared to our initial lead compound, and are promising candidates to treat anthrax infections and diarrheal diseases induced by toxin-producing bacteria.

Related Articles
Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough.
J Biol Chem. 2003
Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough.
Soelaiman S, Wei BQ, Bergson P, Lee YS, Shen Y, Mrksich M, Shoichet BK, Tang WJ. J Biol Chem. 2003 Jul 11; 278(28):25990-7. Epub 2003 Apr 3.
MD simulations of anthrax edema factor: calmodulin complexes with mutations in the edema factor "switch a" region and docking of 3'-deoxy ATP into the adenylyl cyclase active site of wild-type and mutant edema factor variants.
J Biomol Struct Dyn. 2003
MD simulations of anthrax edema factor: calmodulin complexes with mutations in the edema factor "switch a" region and docking of 3'-deoxy ATP into the adenylyl cyclase active site of wild-type and mutant edema factor variants.
Zhao J, Roy SA, Nelson DJ. J Biomol Struct Dyn. 2003 Oct; 21(2):159-70.
Review The adenylyl cyclase activity of anthrax edema factor.
Mol Aspects Med. 2009
Review The adenylyl cyclase activity of anthrax edema factor.
Tang WJ, Guo Q. Mol Aspects Med. 2009 Dec; 30(6):423-30. Epub 2009 Jun 26.
Accounting for ligand-bound metal ions in docking small molecules on adenylyl cyclase toxins.
Proteins. 2007
Accounting for ligand-bound metal ions in docking small molecules on adenylyl cyclase toxins.
Chen D, Menche G, Power TD, Sower L, Peterson JW, Schein CH. Proteins. 2007 May 15; 67(3):593-605.
Review The adenylate cyclase toxins.
Crit Rev Microbiol. 2004
Review The adenylate cyclase toxins.
Ahuja N, Kumar P, Bhatnagar R. Crit Rev Microbiol. 2004; 30(3):187-96.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.